Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Praxis·2026
Same author

Praxis·2026
Same author

The statistical software revolution in pharmaceutical development: challenges and opportunities in open source.

Drug discovery today·2026
Same author

Praxis·2025
Same author

Praxis·2025
Same author

Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint.

Statistical methods in medical research·2025

Related Experiment Videos

Validating and updating a risk model for pneumonia - a case study.

Ulrike Held1, Daniel Sabanes Bové, Johann Steurer

  • 1Horten Centre for Patient Oriented Research and Knowledge Transfer, University Hospital Zurich, Zurich, Switzerland. ulrike.held@usz.ch

BMC Medical Research Methodology
|July 24, 2012
PubMed
Summary
This summary is machine-generated.

Bayesian approaches effectively validate pneumonia risk prediction models. Using a Bayesian model formulation with the original risk prediction rule as prior demonstrated superior predictive performance in external validation.

Related Experiment Videos

Area of Science:

  • Medical Research
  • Biostatistics
  • Clinical Epidemiology

Background:

  • Risk prediction models are crucial in medical research but rarely used in practice.
  • Lack of thorough validation is a key barrier to the implementation of prediction models.
  • This study investigates Bayesian validation methods for pneumonia diagnosis prediction rules.

Purpose of the Study:

  • To compare two Bayesian approaches for validating a pneumonia risk prediction model.
  • To evaluate the predictive performance of these Bayesian methods against established validation techniques.
  • To assess the utility of Bayesian model formulation for external validation of clinical prediction rules.

Main Methods:

  • Developed an expert-derived risk prediction model for pneumonia.
  • Collected data from over 600 patients with cough and fever for validation.
  • Applied cross-validation to quantify calibration and discrimination of various model modifications, including Bayesian approaches.

Main Results:

  • Unshrunk regression coefficients showed poor predictive performance in the validation cohort.
  • Shrinkage improved model performance.
  • A Bayesian model formulation with an informative prior exhibited excellent predictive performance (high AUC, low Brier score), offering flexibility against prior-data conflict.

Conclusions:

  • External validation of published risk prediction rules is essential before clinical use.
  • A Bayesian model formulation utilizing the original rule as a prior is proposed for validation.
  • This Bayesian approach, using posterior means of coefficients, yielded the best cross-validated predictive performance.